12
Jun 2026
Antibody profiles offer insights into long Covid cognitive symptoms
Persistent symptoms after COVID-19 infection continue to affect millions of people worldwide, even as the number of acute infections has declined.
Stay Informed!
12
Jun 2026
No link between cat ownership and asthma flare-ups in children
A study of over 30,000 children reveals no link between cat exposure and asthma outcomes, challenging previous concerns about pet ownership and asthma control.
12
Jun 2026
New gel coating delivers anti-inflammatory antibodies directly to the esophagus
There are few treatment options available for people with disorders of the esophagus. Delivering drugs directly to this part of the body is difficult, so patients are usually treated with systemic drugs, which can have unwanted side effects.
12
Jun 2026
Moderate screen time post concussion may help teens recover faster
New research indicates that balanced screen use after a concussion can accelerate recovery in youth, suggesting a 'Goldilocks' approach to screen time.
12
Jun 2026
Researchers urge one health approach to control raccoon-borne water contamination
The emerging infectious bacterium Escherichia albertii has caused outbreaks of severe food poisoning and hospitalized people through contaminated water and foods, such as salad ingredients. Now, a new study from Osaka Metropolitan University (OMU) has gathered evidence from river, animal and genetic samples that suggest a pathway by which invasive raccoons (Procyon lotor) transmit infections to humans.
12
Jun 2026
PhoreMost announces lead oncology program and appoints Chief Medical Officer to support clinical entry
PhoreMost Limited, a biotech company focused on turning scientific breakthroughs into life-changing cancer drugs, today announced its lead program, PMC-001, a next-generation, small molecule microtubule targeting agent (MTA) for primary and secondary brain cancers.
12
Jun 2026
Biotechnology breakthrough could revolutionize treatment for neurodegenerative diseases
A research team from the School of Biomedical Sciences at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has achieved a significant breakthrough in biotechnology that could revolutionize treatment strategies for neurodegenerative diseases.
11
Jun 2026
New combination therapy improves outcomes in high-risk leukemia
A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel combination therapy that significantly improves treatment outcomes and survival in patients with acute myeloid leukaemia (AML) with FLT3 gene mutations.
11
Jun 2026
Experimental vaccine protects against fentanyl and related opioids
Fentanyl and related variants of the synthetic opioid kill more Americans each year than car accidents and gun violence combined. In too-high doses, the drugs hijack brain chemistry and shut down the signals that control breathing.
11
Jun 2026
Self-help program improves mental health among displaced refugees
A simple self-help workbook paired with brief phone support can make a measurable difference to the mental health of displaced refugees, a new study has found.
